Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of Dentistry
|
March 5, 2014
Dental pulp stem cells: state of the art and suggestions for a true translation of research into therapy
Marcella La Noce, Francesca Paino, Anna Spina, et al.
Animals : an Open Access Journal From MDPI
|
October 24, 2019
Effect of Pegbovigrastim on Hematological Profile of Simmental Dairy Cows during the Transition Period
Francesca Trimboli, Valeria Maria Morittu, Antonio Di Loria, et al.
Immunotherapy
|
October 13, 2020
From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer
Rosa Tambaro, Marilena Di Napoli, Carmela Pisano, et al.
Plos One
|
December 19, 2024
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
Daniela Russo, Anna Spina, Luigi Portella, et al.
Cancer Treatment Reviews
|
August 23, 2020
Immunotherapy in cervix cancer
Laura Attademo, Valentina Tuninetti, Carmela Pisano, et al.
Oncotarget
|
March 1, 2018
Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysis
Francesca Galdiero, Anna Maria Bello, Anna Spina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 16, 2020
Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy
Jole Ventriglia, Immacolata Paciolla, Carmela Pisano, et al.
Cells
|
April 11, 2020
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience
Daniela Califano, Daniela Russo, Giosuè Scognamiglio, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
Marina Fabbi, Delfina Costa, Daniela Russo, et al.
International Journal of Cancer
|
October 17, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study
Eliana Bignotti, Vittorio Simeon, Laura Ardighieri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of Dentistry
|
March 5, 2014
Dental pulp stem cells: state of the art and suggestions for a true translation of research into therapy
Marcella La Noce, Francesca Paino, Anna Spina, et al.
Animals : an Open Access Journal From MDPI
|
October 24, 2019
Effect of Pegbovigrastim on Hematological Profile of Simmental Dairy Cows during the Transition Period
Francesca Trimboli, Valeria Maria Morittu, Antonio Di Loria, et al.
Immunotherapy
|
October 13, 2020
From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer
Rosa Tambaro, Marilena Di Napoli, Carmela Pisano, et al.
Plos One
|
December 19, 2024
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
Daniela Russo, Anna Spina, Luigi Portella, et al.
Cancer Treatment Reviews
|
August 23, 2020
Immunotherapy in cervix cancer
Laura Attademo, Valentina Tuninetti, Carmela Pisano, et al.
Oncotarget
|
March 1, 2018
Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysis
Francesca Galdiero, Anna Maria Bello, Anna Spina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 16, 2020
Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy
Jole Ventriglia, Immacolata Paciolla, Carmela Pisano, et al.
Cells
|
April 11, 2020
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience
Daniela Califano, Daniela Russo, Giosuè Scognamiglio, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
Marina Fabbi, Delfina Costa, Daniela Russo, et al.
International Journal of Cancer
|
October 17, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study
Eliana Bignotti, Vittorio Simeon, Laura Ardighieri, et al.
Page
of 3